For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46...

A gene therapy that could provide a permanent cure for sickle cell disease continues to show success through a third wave of patients, researchers report. The therapy, LentiGlobin, restored normal blood function in 35 sickle cell patients...

A new study confirms yet another consequence of the pandemic for children and teenagers: Eating disorders, and hospitalizations for them, rose sharply in 2020. The study of six hospitals across Canada found new diagnoses of anorexia nearly...

The COVID-19 death toll in the United States reached 800,000 on Monday, and one expert believes it will likely hit 1 million at some point in 2022. The 800,156 confirmed deaths in the nearly two years since...

MONDAY, Dec. 13, 2021 (American Heart Association News) — After four years in a Washington state prison for first-degree burglary, Chelsey Johnson learned she was eligible for a work-release program that would shave the final year off...

Big “surprise” medical bills may still be a problem for Americans. According to a new study, more than half of U.S. hospitals haven’t complied with recent regulations requiring that they disclose their prices online for all services,...

The ability of two-dose COVID-19 vaccines to protect against symptomatic infection by the Omicron variant falls significantly short, but a booster shot provides considerable protection, according to the first real-world study of how effective vaccines are against...

The sound of mom’s voice can soothe a fussy baby like nothing else, but now new research suggests that an infant is also calmed by the scent of its mother. Prior animal studies had already shown that...

First real-world studies into vaccine effectiveness against Omicron. The ability of two-dose COVID-19 vaccines to protect against symptomatic infection by the Omicron variant falls significantly short, British research shows, but a booster shot provides considerable protection. Read...

Parents of children with moderate-to-severe asthma may have a much-needed treatment option: A new trial finds that an injected monoclonal antibody drug called dupilumab significantly reduces a child’s odds of serious asthma attacks and improves lung function....